Searching for a cure for deadly brain tumors
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
August 27, 2021
UC research examining a music app to help breast cancer survivors is mentioned by Forbes.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.
September 23, 2022
The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
May 29, 2024
University of Cincinnati Cancer Center experts will present research on ovarian and blood cancer trials, the link between poor sleep and cancer-related cognitive impairment, and an innovative youth education program at the American Society of Clinical Oncology annual meeting 2024 in Chicago.
May 18, 2021
UC's Daniel Pomeranz Krummel, PhD, discusses new brain cancer research with Liz Bonis on Local 12's What's Happening in Health program.
May 7, 2021
Researchers at the University of Cincinnati, in collaboration with the Georgia Institute of Technology and Emory University, have found that using ultrasound combined with RNA-loaded nanoparticles could help infiltrate the blood-brain barrier and deliver targeted, more effective treatment to brain tumors, while eliminating uncomfortable side effects.
January 5, 2021
Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.
January 8, 2021
Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health, learned he received the placebo in the Moderna vaccine clinical trial. He then received the real vaccine to show that he believes in the science.